PD-1/PD-L1 inhibitor vaccine (THERAVECTYS)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePD-1/PD-L1 inhibitor vaccine (THERAVECTYS)
Drug Alias Namedual PD-1 checkpoint inhibitor/PD-L1 checkpoint inhibitor (THERAVECTYS)
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionProgrammed cell death protein 1 blockersProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1Programmed cell death protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTheravectys Sa
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesTheravectys Sa
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A